EUDA Health Holdings Ltd. Files September 2025 6-K Report

Ticker: EUDAW · Form: 6-K · Filed: Sep 10, 2025 · CIK: 1847846

Sentiment: neutral

Topics: reporting, corporate-info

TL;DR

EUDA Health (formerly 8i Acquisition 2 Corp) filed its Sept 2025 6-K, confirming Singapore HQ and reporting status.

AI Summary

EUDA Health Holdings Ltd. filed a Form 6-K on September 10, 2025, reporting for the month of September 2025. The company, formerly known as 8i Acquisition 2 Corp. until February 24, 2021, is a foreign private issuer based in Singapore. Its principal executive offices are located at 60 Kaki Bukit Place, #03-01 Eunos Techpark, Singapore 415979.

Why It Matters

This filing provides routine updates for EUDA Health Holdings Ltd., a publicly traded company, informing investors about its ongoing reporting status and corporate information.

Risk Assessment

Risk Level: low — This is a routine 6-K filing, typically containing basic corporate information and not announcing significant financial events.

Key Players & Entities

FAQ

What is the primary purpose of this Form 6-K filing?

This Form 6-K is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of September 2025.

What was EUDA Health Holdings Ltd.'s former company name?

EUDA Health Holdings Ltd. was formerly known as 8i Acquisition 2 Corp.

When did the company change its name?

The company's name change from 8i Acquisition 2 Corp. to EUDA Health Holdings Ltd. occurred on February 24, 2021.

Where are EUDA Health Holdings Ltd.'s principal executive offices located?

The principal executive offices are located at 60 Kaki Bukit Place, #03-01 Eunos Techpark, Singapore 415979.

Does EUDA Health Holdings Ltd. file annual reports under Form 20-F?

Yes, the filing indicates that the registrant files annual reports under cover of Form 20-F.

Filing Stats: 371 words · 1 min read · ~1 pages · Grade level 14.5 · Accepted 2025-09-10 16:30:02

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized. Dated: September 10, 2025 EUDA Health Holdings Limited By: /s/ Vivian Tay Name: Vivian Tay Title: Interim Chief Financial Officer

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing